PTC
VIVO

Petrus Trust Company’s Meridian Bioscience Inc VIVO Stock Holding History

Petrus Trust Company’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,401
Closed -$121K – 330
2020
Q1 		$121K Sell
14,401
-5,343
-27% -$45K 0.02% 144
2019
Q4 		$193K Hold
19,744
– – 0.03% 255
2019
Q3 		$187K Buy
19,744
+2,865
+17% +$30.2K 0.03% 241
2019
Q2 		$201K Buy
+16,879
New +$203K 0.04% 236
2017
Q3 		– Sell
-11,302
Closed -$178K – 219
2017
Q2 		$178K Buy
+11,302
New +$163K 0.04% 161

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Petrus Trust Company's VIVO Position: Q2 2020 in Review

Petrus Trust Company sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 14,401 shares — an estimated $121K sold.

Petrus Trust Company first reported a position in VIVO in Q2 2017 and held it in 5 quarters. The position peaked at $201K in Q2 2019. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Petrus Trust Company reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
  • Petrus Trust Company sold 14,401 Meridian Bioscience Inc shares in Q2 2020, an estimated $121K.
  • Petrus Trust Company first reported a position in Meridian Bioscience Inc in Q2 2017 and held it in 5 quarters.
  • Petrus Trust Company's Meridian Bioscience Inc position peaked at $201K in Q2 2019.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Petrus Trust Company's 13F filing for Q2 2020, filed 14 Aug 2020.